Stockscreener 앱 받기
48.23
1.13%
-0.55
시장 영업 전:
48.74
0.51
+1.06%
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - sharewise.com
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo! Finance Australia
Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance
Hims & Hers: Pioneering Customer-Centric Innovation with Premium Valuation - FXLeaders
Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha
Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat
Menopause Care Expansion Could Be a Game Changer for Hims & Hers Health (HIMS) - simplywall.st
Shattering the Stigma around Menopause with Molly Sims in New York City - Hims & Hers Newsroom
Telehealth Stock Could Rebound Off Long-Term Trendline - Schaeffer's Investment Research
Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha
Hims & Hers Health, Inc. (HIMS) Stock forecasts - Yahoo
1 Mid-Cap Stock Worth Your Attention and 2 We Avoid - The Globe and Mail
Hims & Hers Health, Inc. (HIMS) Stock Forecasts - Yahoo
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Why Hims & Hers Stock Slipped Today - AOL.com
Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative
The Problems We’re Solving in Healthcare - Hims & Hers Newsroom
Hims & Hers Advances AI-Powered Personalized Digital Healthcare - Yahoo Finance
Could Hims & Hers Health's (HIMS) Menopause Expansion Reveal a New Competitive Edge in Women's Care? - Yahoo Finance
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026 - Fitt Insider
Hers Health Inc. stockJuly 2025 Outlook & Fast Entry and Exit Trade Plans - newser.com
Hims & Hers (HIMS) Faces Margin Concerns Amid Growth Plans - GuruFocus
CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You? - Barchart.com
Hims & Hers rated Sector Weight at KeyBanc on margin worries - Seeking Alpha
HIMS Stock Declines Despite Launch of New Specialty in Women's Health - Yahoo Finance
Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance (HIMS) - Seeking Alpha
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
HIMS: Keybanc Initiates Coverage with 'Sector Weight' Rating | H - GuruFocus
Hers Health Inc. (82W) stock expanding market penetrationPortfolio Update Report & Precise Buy Zone Identification - newser.com
Investor Mood: Hers Health Inc. stock undervalued after correctionLong Setup & Long-Term Safe Investment Plans - nchmf.gov.vn
Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright - Seeking Alpha
Hims & Hers CFO Okupe sells $662k in shares - Investing.com
Hims & Hers Health CFO Sells Shares Under Trading Plan - TradingView
HIMS CFO exercises options, sells 11,592 shares under Rule 10b5-1 - Stock Titan
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know - Yahoo Finance
Hims & Hers Health: Roller Coaster Gift (NYSE:HIMS) - Seeking Alpha
HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms - Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Hers Health Inc.July 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Avoiding Lag: Real-Time Signals in (HIMS) Movement - news.stocktradersdaily.com
Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations - Yahoo Finance
Should the New Menopause Specialty and CEO Share Sale Prompt a Closer Look at HIMS? - simplywall.st
Why Hims & Hers stock is failing to retain menopause gains and what comes next? - CryptoRank
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet - Benzinga
Hims & Hers CEO sells, analyst calls on Planet Fitness & Deere - Yahoo Finance
Hims & Hers stock sinks amid launch of menopause care - The Business Journals
Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake - Yahoo Finance
Hims & Hers Health (HIMS) Stock Tanks 15% after CEO Discloses Stock Sale - TipRanks
Hims & Hers Health (HIMS) Stock Declines Following CEO's Major S - GuruFocus
Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom - ts2.tech
Why Is Hims & Hers Health Stock Down 12% Today? - MSN
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
Hims & Hers Health down 11% after CEO Dudum stock sale disclosure - Seeking Alpha
Hims & Hers Health stock falls after Trump promises lower weight loss drug prices - Investing.com
Why Hims & Hers Health Shares Are Sliding Friday - Benzinga
Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Platform Launch - Quiver Quantitative
Hims & Hers: Navigating Financial Challenges - timothysykes.com
GoodRx challenges Hims & Hers in D2C prescription drug market - eMarketer
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - sharewise.com
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' - Benzinga
Hims & Hers CEO sells stock after menopause expansion announcement - Sherwood News
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Barchart.com
Hims & Hers Elevates Technology-Driven Healthcare Accessibility - Nasdaq
1.00%
0.75%
자본화:
|
볼륨(24시간):